Dr. Aaron Royston has served as an Achieve Life Sciences director since 2026 and serves on the Nominating and Governance Committee. He has been a managing partner at venBio Partners, a life-sciences investment firm, since April 2020 and has been with the firm since 2015; he previously was a Senior Associate at Vivo Capital and a consultant at Bain & Company. Dr. Royston has served on the boards of RayzeBio, Ventyx Biosciences, Akero Therapeutics and VYNE Therapeutics, as well as several private companies. He received a B.S. in biological sciences from Duke University and an M.D. and M.B.A. from the University of Pennsylvania.